ANIP 56.91 Stock Price ANI Pharmaceuticals, Inc.
Range: | 48.2-70.81 | Vol Avg: | 316867 | Last Div: | 0 | Changes: | 1.05 |
Beta: | 0.71 | Cap: | 1.20B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Fri May 05 2000 | Empoloyees: | 642 |
CUSIP: | 00182C103 | CIK: | 0001023024 | ISIN: | US00182C1036 | Country: | US |
CEO: | Mr. Nikhil Lalwani | Website: | https://www.anipharmaceuticals.com |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.